AlexisAllysonMeltonMD

Pediatric Hematology & Oncology • San Francisco, CA

Clinical Fellow in Pediatrics, Boston Children's Hospital

Join to view full profile

Dr. Melton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Melton's full profile

Already have an account?

Office
550 16th St 434
San Francisco, CA 94158
Phone+1 415-476-3831

Fax+1 415-353-2765

Education & Training

University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2012 - 2015
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2009 - 2012
University of Texas Southwestern Medical SchoolClass of 2009

Certifications & Licensure

CA State Medical License 2011 - 2025
TX State Medical License 2018 - 2018
MA State Medical License 2009 - 2012
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

8 citations
A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study.
Geoffrey D E Cuvelier, Bernard Ng, Sayeh Abdossamadi, Eneida R Nemecek, Alexis Melton
Blood Advances. 2023-07-25
16 citations
A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patients.
Christine S Higham, Kristin A Shimano, Alexis Melton, Sandhya Kharbanda, Julia Chu
Pediatric Blood & Cancer. 2022-05-01
2 citations
Hematopoietic Cell Transplant-Comorbidity Index Score is Correlated with Treatment Related Mortality and Overall Survival following Second Allogeneic Hematopoietic Cel...
Federica Forlanini, Matt S. Zinter, Christopher C. Dvorak, Mara Bailey-Olson, Lena E. Winestone
Transplantation and Cellular Therapy. 2021-11-27

Abstracts/Posters

Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants
Alexis Melton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis
Alexis Melton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

Final Four ‘Wish’ Granted to Young Survivor of Rare Immune DiseaseApril 4th, 2018